Sentence examples for pathways that lack from inspiring English sources

Metabolic pathways that lack redundancy or have critical functions have been identified previously through essential gene studies.

All have failed to find the "interactions" or gene relationships in the specific pathways that lack "graphID" entry.

Concluding, our models show that the control of transposon activity can be achieved by alternative pathways that lack RdRP and act through different feedback mechanisms.

In analogy to ubiquitin E2-like variants of the ubiquitin/proteasome pathways that lack active site cysteine residues and form heterodimers with E2 enzymes (VanDemark et al., 2001), SERAser, while catalytically inactive on their own, could act in concert with canonical SERAcys proteases and provide crucial substrate binding sites.

R. eutropha H16 has an incomplete glycolytic pathway that lacks in phosphofructokinase (E.C. 2.7.1.11) encoded by pfk, which converts fructose 6-phosphate to fructose 1,6-bisphosphate, but instead utilizes the ED pathway to catabolize D-fructose and other hexoses [ 31, 32].

Individuals with BTHS are characterized by pleiotropic respiratory defects (Barth et al., 1996), possibly because of impaired respirasome stability (McKenzie et al., 2006), have low levels of CL, and accumulate monolysocardiolipin (MLCL), an intermediate in the CL remodeling pathway that lacks an acyl chain, in various tissues and cells (Schlame et al., 2003; Valianpour et al., 2005).

As expected, Group II peptides are derived from pathways that also lack heterocyclases.

First-generation engineering work much of it with single genes—has successfully introduced osmoprotectant pathways into plants that lack them naturally, and this has often improved stress tolerance.

These are candidates for pathways that sense the lack of V-ATPase activity independently of the effect on transferrin or LDL.

The analyses of global gene expression signature will potentially yield the dominant pathways that result from lack of tumor suppressor or contextual regulated genes, and allow exploitation as therapeutic targets or biomarkers of clinical outcome.

In the current study, we demonstrated enhanced immune cell recruitment and reduced T cell co-inhibitory pathways in tumors that lack mammary epithelial expression of the pro-inflammatory enzyme COX-2, coincident with delayed ErbB2 oncogene-driven mammary tumor development.